JUNIUS DANIEL M — SEC Form 4 filings
SEC reporting owner CIK 1094159. 8 Form 4 filings on record with FilingPulse; latest filed 2026-05-14.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-01 to 2026-05-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 2,683 shares, $1,358,697 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 2,683 shares @ $506.41 ($1,358,697) in IDEXX LABORATORIES INC /DE, filed 2025-05-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IDEXX LABORATORIES INC /DE (IDXX) | Director | 6 | — | 1 leg · 2,683 sh · $1,358,697 | 15 |
| GLYCOMIMETICS INC (GLYC) | Director | 2 | — | — | 2 |
Form 4 filings — JUNIUS DANIEL M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-14 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 525 (derivative) @ $0 · Grant/award (A): 234 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Option exercise (M): 257 @ $0 · Option exercise (M): 257 (derivative) | EDGAR |
| 2025-05-14 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Option exercise (M): 1,404 @ $245.79 · Option exercise (M): 1,279 @ $283.59 · Sale (S): 2,683 @ $506.41 · Option exercise (M): 1,404 (derivative) @ $0 · Option exercise (M): 1,279 (derivative) @ $0 | EDGAR |
| 2025-05-08 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Option exercise (M): 262 @ $0 · Option exercise (M): 262 (derivative) @ $0 · Grant/award (A): 600 (derivative) @ $0 · Grant/award (A): 257 (derivative) @ $0 | EDGAR |
| 2024-05-08 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 609 (derivative) @ $0 · Grant/award (A): 262 (derivative) @ $0 | EDGAR |
| 2024-05-01 | 4 | GLYCOMIMETICS INC (GLYC) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | GLYCOMIMETICS INC (GLYC) | Grant/award (A): 5,209 @ $3 | EDGAR |
| 2024-02-01 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 14 @ $521.03 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1094159 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →